The Hyaluronic Viscosupplementation Market is experiencing a substantial surge in demand as it emerges as a leading solution for individuals seeking relief from joint pain and mobility issues. Hyaluronic viscosupplementation involves injecting hyaluronic acid-based formulations into joints affected by osteoarthritis, providing lubrication and cushioning to reduce pain and improve joint function.
With a growing aging population and increased sports-related injuries, joint disorders have become a prevalent health concern worldwide. As a minimally invasive and effective treatment option, hyaluronic viscosupplementation is gaining popularity among patients and healthcare providers alike.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17713
The global market for hyaluronic viscosupplementation is expected to grow at a significant rate in the coming years, driven by several factors including increasing rising knee injuries around the globe and increasing cases of falls. The global market currently stands at US$ 2.3 Billion in 2022, and it is further projected to expand at a CAGR of 5.2% over the forecast period (2023 to 2033).
The World Health Organization highlights osteoarthritis (OA) as a significant contributor to functional disability in older adults, affecting 9.6% of men and 18% of women aged over 60 years.
Viscosupplements, containing hyaluronic acid, are being used to improve viscoelasticity, reduce symptoms, and enhance joint functionality. These molecules are incorporated with anti-inflammatory drugs to improve short-term pain relief and enhance the bioactive principle at the injured cartilage site. Combining viscosupplements with regenerative therapies is promising for stimulating intrinsic cartilage repair and regeneration. The cost of treatment is minimum and affordable for all sections of patients.
In general, the hyaluronic viscosupplementation market is likely to expand more in the coming years. This market provides people with a cheaper and more convenient way to improve their joint condition.
Key Takeaways:
- By product, three injection knee hyaluronic acid injection accounts for US$ 1.14 Billion in 2022 owing to the benefits provided in knee osteoarthritis pain.
- By indication, knee osteoarthritis accounted for US$ 2.0 Billion in 2022. Knee osteoarthritis (OA) is a prominent joint disease affecting the quality of life and socioeconomic impact, causing job losses. It affects more than 40% of adults globally and leads to poor or fair health, affecting non-institutionalized adults.
- By molecular weight, high molecular weight hyaluronic viscosupplementation contributed around US$ 1.6 Billion in 2022. Due to the high polymer chain, it easily enters the tissue and has better activity anti-inflammatory activity than low molecular weight hyaluronate.
- By body part, Knee held more than 85.0% of global market share in 2022. As knees are most commonly affected by the osteoarthritis-like condition as one grows older, viscosupplementation in knee osteoarthritis treatments may offer cost-effectiveness and delay total arthroplasty.
- Hospitals and ambulatory surgical centers together held more than 55.0% of the global market share in 2022. This can be ascribed to the fact that the prominent of the world’s population suffers from diseases and obesity, which can be adequately identified in these settings with qualified assistance.
- By region, North America held the dominant share of the world in 2022. The U.S. leads in this region with a high prevalence of osteoarthritis and a high requirement of viscosupplementation therapy.
“The rising cases of osteoarthritis and increase in the adoption rate of viscosupplementation treatment contribute to its higher demand and global expansion.”says an analyst of Future Market Insights.
Market Competition of Hyaluronic Viscosupplementation Market:
The hyaluronic viscosupplementation market is highly competitive, with key players including Anika Therapeutics and Seikagaku. These companies are constantly participating in conferences, award competitions with their products, and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.
- In July 2022, Anika Therapeutics wins ACE Award for Tactoset, a biocompatible, easily injectable, and interdigitating bone graft substitute in Sports Medicine, enhancing hardware augmentation.
- In August 2021, Seikagaku launches HyLink® for knee osteoarthritis treatment in Taiwan.
Key Players:
- Anika Therapeutics Inc.
- Zimmer Biomet
- Sanofi S.A.
- LG Chem
- Chugai Pharmaceutical Co., Ltd.
- Meiji Seika Pharma co. ltd
- Ferring B.V.
- Hanmi Pharm.Co., Ltd.
- Anika Therapeutics, Inc.
- Fidia Farmaceutici s.p.a.
- Bioventus LLC
- OrthogenRx
- Seikagaku Corporation
- Bioiberica S.A.U.
- APTISSEN
- Hangzhou Singclean Medical Products Co., Ltd
- Maxigen Biotech Inc.
- TRB Chemedica International SA
- Yuria-Pharm LLC
- Haohai Biological Technology
- Chroma Pharma
Hyaluronic Viscosupplementation Market: Comprehensive Report Coverage:
Future Market Insights offers a unique perspective and actionable insights on the hyaluronic viscosupplementation in its latest study, presenting a historical demand assessment of 2012 to 2022 and projections for 2023 to 2033. The global hyaluronic viscosupplementation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader
The analysis is based on the product (single injection, three injections, five injections, and next-generation (steroid combination)), body parts (knee, hip, shoulder, small joints, and others), molecular weight (high molecular weight, medium molecular weight, low molecular weight), indication (knee osteoarthritis, tendinopathies, shoulder arthritis, hip osteoarthritis, frozen shoulder, ligament injury, post-arthroscopy, and others) end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales), across seven key regions around the world.
Unlock Tailored Insights: Customize Your Report for Maximum Impact:https://www.futuremarketinsights.com/customization-available/rep-gb-17713
Key Segments:
By Product:
- Single Injection Knee Hyaluronic Acid Injections
- Three Injection Knee Hyaluronic Acid Injections
- Five Injection Knee Hyaluronic Acid Injections
- Next Generation (Steroid Combination)
By Body Parts:
- Knee
- Hip
- Shoulder
- Small Joints
- Others
By Molecular Weight:
- High Molecular Weight
- Medium Molecular Weight
- Low Molecular Weight
By Indication:
- Knee Osteoarthritis
- Tendinopathies
- Shoulder Arthritis
- Hip Osteoarthritis
- Frozen Shoulder
- Ligament Injury
- Post-Arthroscopy
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube